Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a “Site Management Organisation” (SMO) specialised in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people.
Thanks to its shareholder, the Fondation Transplantation, a non profit organisation, FORENAP makes use of public research network.
FORENAP Group is made of two main lines of skills :
- FORENAP Pharma : preclinical and clinical studies management as well as related business activities;
- FORENAP FRP : dedicated to scientific research.
FORENAP proposes optimised development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre, FORENAP conducts :
- Standard clinical pharmacology studies
"First in man", repeated doses, pharmacokinetics, bioavailability, food and drug interactions... - Specific populations studies
Poor metabolisers, insomniac, post-menopausal, obese, elderly... - Proof of concept" studies
Phamacodynamic, human models, central nervous system (CNS), cardiovascular system... - Patients studies
FORENAP offers a “full services package” ( including “consulting” services) to bring your projects to success, from Drug Discovery to Marketing authorization.
Choosing the exclusive in-house technology and expertise of Forenap Pharma is the most efficient strategy
to improve your drug development.
